neonatal hyperbilirubinemia and symbiotic effect on its treatment.
Conditions
Interventions
Intervention 1: Intervention group will receive 5 drops of oral Pedilact before breast feeding, once a day, until the day of discharge in addition to routine phototherapy,. Pedilact is a Synbiotic an
Sponsors
Rasht University of Medical Sciences
Eligibility
Sex/Gender
All
Age
3 Days to 14 Days
Inclusion criteria
Inclusion criteria: Age between 3-14 days Total bilirubin between 15-22 mg/dl and direct bill 2500gr
Exclusion criteria
Exclusion criteria: Sepsis Cephalhematoma ABO incompatibility G6PD deficiency Underlying disease Parental dissatisfaction Polycythemia RH incompatibility Formula feeding Treated by Phenobarbital .billinaster.etc... Transfer to NICU Down Syndrome Family history of Immune deficiency Blood exchange Treated by Antibiotics Serum therapy Hemolysis Diabetes in Mother
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Daily defecation numbers. Timepoint: Daily at 8 AM until discharge. Method of measurement: Question from parents. | — |
Primary
| Measure | Time frame |
|---|---|
| Bilirubin level. Timepoint: Measurement of Bilirubin in admission day and daily until discharge(8 AM). Method of measurement: Measurement of serum bilirubin in laboratory by Pars Azmoon kits. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyedeh Azadeh Hosseini Nouri
Rasht University of Medical Sciences
Outcome results
None listed